Who is sponsoring NCT03504891?

NCT03504891 is sponsored by University of Virginia.

What drugs are being tested in NCT03504891?

Interventions in NCT03504891: MRI prior to CRT Upgrade, MRI prior to de novo CRT.

What condition does NCT03504891 study?

NCT03504891 studies Chronic Systolic Heart Failure, Paroxysmal VT.

Is NCT03504891 still recruiting?

NCT03504891 is currently status unknown. Last updated 3 May 2018.

Last reviewed 2018-05-03 · How we verify

NCT03504891

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiac MRI for Optimal Heart Failure Outcomes With CRT Upgrades

Status unknown Phase 1 Last updated 3 May 2018

What this trial tests

Phase 1 trial testing MRI prior to CRT Upgrade in Chronic Systolic Heart Failure in 50 participants. Status unknown.

Timeline

1 January 2018

Primary endpoint
1 January 2020

1 January 2020

Quick facts

Lead sponsor	University of Virginia
Phase	Phase 1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 January 2018
Primary completion	1 January 2020
Estimated completion	1 January 2020
Sites	1 location across United States

Drugs / interventions tested

MRI prior to CRT Upgrade
MRI prior to de novo CRT

Conditions studied

Chronic Systolic Heart Failure — all drugs for Chronic Systolic Heart Failure →
Paroxysmal VT — all drugs for Paroxysmal VT →

Sponsor

University of Virginia

Who can join

Adults 25 to 89, any sex, with Chronic Systolic Heart Failure or Paroxysmal VT. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the use of cardiac MRI in patients with standard ICDs and pacemakers to inform how cardiac resynchronization therapy (CRT) can best be implemented in these patient and which patients are the best candidates for CRT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Virginia trials

Trials by the same sponsor.

NCT05880355 — Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI · EARLY_PHASE1 · not yet recruiting
NCT07405645 — Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy · NA · recruiting
NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study · Phase 4 · not yet recruiting
NCT07298941 — Resilience Enhancement Following Sleep Treatment · Phase 2 · recruiting
NCT07036315 — Meaning in Music-Based Pain Modulation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03504891 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Virginia
Last refreshed: 3 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03504891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing